ONLINE DATABASE SEARCH -
DMID-LS-127-MEMO
1.
58918 DMID-LS-127;
PUBMED-DMID-9/11/2006
Human cytomegalovirus infection alters the substrate specificities and
rapamycin sensitivities of raptor- and rictor-containing
complexes
Kudchodkar, SB, Yu, Y, Maguire, TG, and Alwine, JC
Proc Natl Acad Sci U S A 2006.
View Data on the NIAID Therapeutics Website
HYPERLINK:
2.
58919 DMID-LS-127;
PUBMED-DMID-9/11/2006
Efficient Large-Scale Synthesis of BILN 2061, a Potent HCV Protease
Inhibitor, by a Convergent Approach Based on Ring-Closing
Metathesis
Yee, NK, Farina, V, Houpis, IN, Haddad, N, Frutos, RP, Gallou, F, Wang,
XJ, Wei, X, Simpson, RD, Feng, X, Fuchs, V, Xu, Y, Tan, J, Zhang, L, Xu, J,
Smith-Keenan, LL, Vitous, J, Ridges, MD, Spinelli, EM, Johnson, M, Donsbach, K,
Nicola, T, Brenner, M, Winter, E, Kreye, P, and Samstag, W
J Org Chem 2006.
71(19): 7133-45
View Data on the NIAID Therapeutics Website
HYPERLINK:
3.
58920 DMID-LS-127;
SCIFINDER-DMID-9/11/2006
N-halogenated and N,N-dihalogenated amino acids in combination with
hypohalous acids for use as antimicrobial agents
Najafi, Ramin, Bassiri, Mansour, Wang, Lu, and Khosrovi,
Behzad
PATENT: WO
2006081392 ISSUE DATE: 20060803
APPLICATION: 2006 PP:
72pp.
ASSIGNEE: (Novacal
Pharmaceuticals, Inc. USA
View Data on the NIAID Therapeutics Website
HYPERLINK:
4.
58921 DMID-LS-127;
PUBMED-DMID-9/11/2006
Nitric oxide and peroxynitrite have different antiviral effects against
hantavirus replication and free mature virions
Klingstrom, J, Akerstrom, S, Hardestam, J, Stoltz, M, Simon, M, Falk, KI,
Mirazimi, A, Rottenberg, M, and Lundkvist, A
Eur J Immunol 2006.
View Data on the NIAID Therapeutics Website
HYPERLINK:
5.
58922 DMID-LS-127;
PUBMED-DMID-9/11/2006
Antiviral effect of octyl gallate against DNA and RNA
viruses
Uozaki, M, Yamasaki, H, Katsuyama, Y, Higuchi, M, Higuti, T, and Koyama,
AH
Antiviral Res 2006.
View Data on the NIAID Therapeutics Website
HYPERLINK:
6.
58923 DMID-LS-127;
PUBMED-DMID-9/11/2006
Natural products that reduce rotavirus infectivity identified by a
cell-based moderate-throughput screening assay
Shaneyfelt, ME, Burke, AD, Graff, JW, Jutila, MA, and Hardy,
ME
Virol J 2006. 3(1): 68
View Data on the NIAID Therapeutics Website
HYPERLINK:
7.
58924 DMID-LS-127;
PUBMED-DMID-9/11/2006
Molecular modeling studies of peptide drug candidates against
SARS
Zhang, R, Wei, DQ, Du, QS, and Chou, KC
Med Chem 2006. 2(3):
309-14
View Data on the NIAID Therapeutics Website
HYPERLINK:
8.
58925 DMID-LS-127;
PUBMED-DMID-9/11/2006
Antiviral Targets of a Chromene Derivative from Sargassum micracanthum in
the Replication of Human Cytomegalovirus
Hayashi, K, Mori, J, Saito, H, and Hayashi, T
Biol Pharm Bull 2006.
29(9): 1843-7
View Data on the NIAID Therapeutics Website
HYPERLINK:
9.
58926 DMID-LS-127;
PUBMED-DMID-9/11/2006
Synthesis of pyrrolo[2,3-d]pyrimidine nucleoside derivatives as potential
anti-HCV agents
Varaprasad, CV, Ramasamy, KS, Girardet, JL, Gunic, E, Lai, V, Zhong, W,
An, H, and Hong, Z
Bioorg Chem
2006.
View Data on the NIAID Therapeutics Website
HYPERLINK:
10.
58927 DMID-LS-127;
PUBMED-DMID-9/11/2006
Inhibition of the replication of hepatitis B virus in vitro by
emodin
Shuangsuo, D, Zhengguo, Z, Yunru, C, Xin, Z, Baofeng, W, Lichao, Y, and
Yan'an, C
Med Sci Monit 2006.
12(9): BR302-306
View Data on the NIAID Therapeutics Website
HYPERLINK:
11.
58928 DMID-LS-127;
PUBMED-DMID-9/11/2006
NIM811, a Cyclophilin Inhibitor, Exhibits Potent In Vitro Activity
against Hepatitis C Virus Alone or in Combination with Alpha
Interferon
Ma, S, Boerner, JE, Tiongyip, C, Weidmann, B, Ryder, NS, Cooreman, MP,
and Lin, K
Antimicrob Agents Chemother 2006. 50(9): 2976-82
View Data on the NIAID Therapeutics Website
HYPERLINK:
12.
58929 DMID-LS-127;
SCIFINDER-DMID-9/11/2006
Antiviral activity from medicinal mushrooms
Stamets, Paul
PATENT: US
2006171958 ISSUE DATE: 20060803
APPLICATION: 2006-58722 PP:
14pp., Cont.-in-part of U.S. Ser. No. 145,679.
ASSIGNEE:
(USA)
View Data on the NIAID Therapeutics Website
HYPERLINK:
13.
58930 DMID-LS-127;
PUBMED-DMID-9/11/2006
Natural variation can significantly alter sensitivity to oseltamivir of
Influenza A(H5N1) viruses
Rameix-Welti, MA, Agou, F, Buchy, P, Mardy, S, Aubin, JT, Veron, M, van,
der Werf S, and Naffakh, N
Antimicrob Agents Chemother 2006.
View Data on the NIAID Therapeutics Website
HYPERLINK:
14.
58931 DMID-LS-127;
PUBMED-DMID-9/11/2006
Synergistic effect of a novel oxymatrine-baicalin combination against
hepatitis B virus replication, alpha smooth muscle actin expression and type I
collagen synthesis in vitro
Cheng, Y, Ping, J, Xu, HD, Fu, HJ, and Zhou, ZH
World J Gastroenterol 2006.
12(32): 5153-9
View Data on the NIAID Therapeutics Website
HYPERLINK:
15.
58932 DMID-LS-127;
PUBMED-DMID-9/11/2006
Structure-based design of a novel thiazolone scaffold as HCV NS5B
polymerase allosteric inhibitors
Yan, S, Appleby, T, Larson, G, Wu, JZ, Hamatake, R, Hong, Z, and Yao,
N
Bioorg Med Chem Lett 2006.
View Data on the NIAID Therapeutics Website
HYPERLINK:
16.
58933 DMID-LS-127;
PUBMED-DMID-9/11/2006
Temperature sensitive influenza A virus genome replication results from
low thermal stability of polymerase-cRNA complexes
Dalton, RM, Mullin, AE, Amorim, MJ, Medcalf, E, Tiley, LS, and Digard,
P
Virol J 2006. 3(1):
58
View Data on the NIAID Therapeutics Website
HYPERLINK:
17.
58934 DMID-LS-127;
PUBMED-DMID-9/11/2006
CD4 T cell-mediated protection from lethal influenza: perforin and
antibody-mediated mechanisms give a one-two punch
Brown, DM, Dilzer, AM, Meents, DL, and Swain, SL
J Immunol 2006.
177(5): 2888-98
View Data on the NIAID Therapeutics Website
HYPERLINK:
18.
58935 DMID-LS-127;
PUBMED-DMID-9/11/2006
Improving anti-hepatitis C virus therapy
Pol, S and Mallet, VO
Expert Opin Biol Ther 2006.
6(9): 923-33
View Data on the NIAID Therapeutics Website
HYPERLINK:
19.
58936 DMID-LS-127;
SCIFINDER-DMID-9/11/2006
Synthesis of
2-bromo-6-octylamino-1-b-D-ribofuranosylimidazo[4,5-e][1,3]diazepine-4,8-dione:
A Ring-expanded nucleoside analog with a therapeutic promise against
Flaviviridae
Zhang, Peng, Zhang, Ning, and Hosmane, Ramachandra
S
Abstracts of Papers, 232nd ACS National Meeting, San Francisco, CA,
United States, Sept. 10-14, 2006 2006.: MEDI-231
View Data on the NIAID Therapeutics Website
HYPERLINK:
20.
58937 DMID-LS-127;
PUBMED-DMID-9/11/2006
Importance of neuraminidase active-site residues to the neuraminidase
inhibitor resistance of influenza viruses
Yen, HL, Hoffmann, E, Taylor, G, Scholtissek, C, Monto, AS, Webster, RG,
and Govorkova, EA
J Virol 2006. 80(17):
8787-95
View Data on the NIAID Therapeutics Website
HYPERLINK:
21.
58938 DMID-LS-127;
PUBMED-DMID-9/11/2006
West Nile virus 5'-cap structure is formed by sequential guanine N-7 and
ribose 2'-O methylations by nonstructural protein 5
Ray, D, Shah, A, Tilgner, M, Guo, Y, Zhao, Y, Dong, H, Deas, TS, Zhou, Y,
Li, H, and Shi, PY
J Virol 2006. 80(17):
8362-70
View Data on the NIAID Therapeutics Website
HYPERLINK:
22.
58939 DMID-LS-127;
PUBMED-DMID-9/11/2006
Corneal toxicity of cell-penetrating peptides that inhibit Herpes simplex
virus entry
Akkarawongsa, R, Cullinan, AE, Zinkel, A, Clarin, J, and Brandt,
CR
J Ocul Pharmacol Ther 2006.
22(4): 279-89
View Data on the NIAID Therapeutics Website
HYPERLINK:
23.
58940 DMID-LS-127;
SCIFINDER-DMID-9/11/2006
Anticancer and antiviral activities of organotin polyether amines derived
from the antiviral acyclovir
Roner, Michael R, Carraher, Charles E, Sabir, Theodore S, Shahi, Kim,
Roehr, Joanne L, and Bassett, Kelly D
Abstracts of Papers, 232nd ACS National Meeting, San Francisco, CA,
United States, Sept. 10-14, 2006 2006.: PMSE-303
View Data on the NIAID Therapeutics Website
HYPERLINK:
24.
58941 DMID-LS-127;
SCIFINDER-DMID-9/11/2006
Isoindolylureas a new group of antiviral compounds
Verma, Manjusha and Singh, Krishna Nand
Abstracts of Papers, 232nd ACS National Meeting, San Francisco, CA,
United States, Sept. 10-14, 2006 2006.: MEDI-226
View Data on the NIAID Therapeutics Website
HYPERLINK:
25.
58942 DMID-LS-127;
SCIFINDER-DMID-9/11/2006
Pyrroloquinolines as human cytomegalovirus polymerase inhibitors: SAR of
arylethanolamine side-chain at C-8
Nair, Sajiv K, Schultz, Brenda L, Nieman, James A, Heasley, Steven E,
Vaillancourt, Valerie A, and Brammer, Carolyn A
Abstracts of Papers, 232nd ACS National Meeting, San Francisco, CA,
United States, Sept. 10-14, 2006 2006.: MEDI-224
View Data on the NIAID Therapeutics Website
HYPERLINK:
26.
58943 DMID-LS-127;
SCIFINDER-DMID-9/11/2006
Detection of influenza viruses resistant to neuraminidase inhibitors in
global surveillance during the first 3 years of their use
Monto Arnold S, McKimm-Breschkin Jennifer L, Macken Catherine, Hampson
Alan W, Hay Alan, Klimov Alexander, Tashiro Masato, Webster Robert G, Aymard
Michelle, Hayden Frederick G, and Zambon Maria
Antimicrobial agents and chemotherapy 2006. 50(7): 2395-402.
View Data on the NIAID Therapeutics Website
HYPERLINK:
27.
58944 DMID-LS-127;
WOS-DMID-9/11/2006
Practical Synthesis of
2-(2-Isopropylaminothiazol-4-Yl)-7-Methoxy-1h-Quinolin-4-One: Key Intermediate
for the Synthesis of Potent Hcvns3 Protease Inhibitor Biln 2061
Frutos, R. et al.
Synthesis-Stuttgart 2006.(15): 2563-2567
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239924200017
28.
58945 DMID-LS-127;
WOS-DMID-9/11/2006
The Structure of the Endoribonuclease Xendou: From Small Nucleolar Rna
Processing to Severe Acute Respiratory Syndrome Coronavirus
Replication
Renzi, F. et al.
Proceedings of the National
Academy of Sciences of the United States of America 2006. 103(33):
12365-12370
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239867500031
29.
58946 DMID-LS-127;
WOS-DMID-9/11/2006
Inhibition of Viral Proteases by Zingiberaceae Extracts and Flavones
Isolated From Kaempferia Parviflora
Sookkongwaree, K. et al.
Pharmazie 2006.
61(8): 717-721
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239907900016
30.
58947 DMID-LS-127;
SCIFINDER-DMID-9/11/2006
8-Azabicyclo[3.2.1]octane derivatives with an activity on chemokine CCR5
receptors and their preparation, pharmaceutical compositions and use for
treatment of inflammatory diseases and infection caused by HIV and genetically
related retroviruses
Pryde, David Cameron and Stupple, Paul Anthony
PATENT: WO
2006067584 ISSUE DATE: 20060629
APPLICATION: 2005 PP: 67
pp.
ASSIGNEE: (Pfizer Limited,
UK
View Data on the NIAID Therapeutics Website
HYPERLINK:
31.
58948 DMID-LS-127;
WOS-DMID-9/11/2006
A 5 ' Rna Element Promotes Dengue Virus Rna Synthesis on a Circular
Genome
Filomatori, C. et al.
Genes & Development 2006. 20(16): 2238-2249
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239790600008
32.
58949 DMID-LS-127;
WOS-DMID-9/11/2006
Bk Virus Infection in Transplant Recipients: an Overview and
Update
Randhawa, P. and Brennan, D.
American Journal of Transplantation 2006. 6(9): 2000-2005
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239617800003
33.
58950 DMID-LS-127;
SCIFINDER-DMID-9/11/2006
Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic
derivatives of glycopeptide antibiotics
Balzarini, Jan, Keyaerts, Els, Vijgen, Leen, Egberink, Herman, De Clercq,
Erik, Van Ranst, Marc, Printsevskaya, Svetlana S, Olsufyeva, Eugenia N,
Solovieva, Svetlana E, and Preobrazhenskaya, Maria N
Antiviral Research 2006.
72(1): 20-33
View Data on the NIAID Therapeutics Website
HYPERLINK:
34.
58951 DMID-LS-127;
WOS-DMID-9/11/2006
Utilization of Ribozymes as Antiviral Agents
Benitez-Hess, M. and Alvarez-Salas, L.
Letters in Drug Design & Discovery 2006. 3(6): 390-404
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239768400005
35.
58952 DMID-LS-127;
WOS-DMID-9/11/2006
Antiviral Defense: Interferons and Beyond
Stetson, D. and Medzhitov, R.
Journal of Experimental Medicine 2006. 203(8): 1837-1841
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239603600003
36.
58953 DMID-LS-127;
SCIFINDER-DMID-9/11/2006
Antiviral effects of saikosaponins on human coronavirus 229E in
vitro
Cheng, Pei-Win, Ng, Lean-Teik, Chiang, Lien-Chai, and Lin,
Chun-Ching
Clinical and Experimental Pharmacology and Physiology 2006. 33(7): 612-616
View Data on the NIAID Therapeutics Website
HYPERLINK:
37.
58954 DMID-LS-127;
WOS-DMID-9/11/2006
The Anti-Viral Effects of Interferon-Alpha on Varicella-Zoster Virus
(Vzv).
Ku, C., Schaap, A., and
Arvin, A.
Clinical Immunology 2006.
119: S181
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000237924300482
38.
58955 DMID-LS-127;
WOS-DMID-9/11/2006
Alkoxyakl Esters of (S)-9-[3-Hydroxy-2-(Phosphonomethoxy)Propyl] Adenine
Are Potent Inhibitors of the Replication of Wild-Type and Drug-Resistant Human
Immunodeficiency Virus Type 1 in Vitro
Hostetler,
K. et
al.
Antimicrobial Agents and Chemotherapy 2006. 50(8): 2857-2859
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239640400040
39.
58956 DMID-LS-127;
SCIFINDER-DMID-9/11/2006
Furin inhibitors and a-defensins for the treatment or prevention of
papillomavirus infection
Day, Patricia M, Richards, Rebecca, Buck, Christopher, Schiller, John T,
and Lowy, Douglas R
PATENT: WO
2006084131 ISSUE DATE: 20060810
APPLICATION: 2006 PP:
94pp.
ASSIGNEE: (The Government of
the United States of America, As Represented by the Secretary Department of
Health and Human Services USA
View Data on the NIAID Therapeutics Website
HYPERLINK:
40.
58957 DMID-LS-127;
SCIFINDER-DMID-9/11/2006
Carrageenan is a potent inhibitor of papillomavirus
infection
Buck, Christopher B, Thompson, Cynthia D, Roberts, Jeffrey N, Muller,
Martin, Lowy, Douglas R, and Schiller, John T
PLoS Pathogens
2006. 2(7):
671-680
View Data on the NIAID Therapeutics Website
HYPERLINK:
41.
58958 DMID-LS-127;
WOS-DMID-9/11/2006
Role of T Cells, Cytokines and Antibody in Dengue Fever and Dengue
Haemorrhagic Fever
Fink, J., Gu, F., and Vasudevan, S.
Reviews in Medical Virology 2006. 16(4): 263-275
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239523800005
42.
58959 DMID-LS-127;
WOS-DMID-9/11/2006
Decision Analysis in Planning for a Polio Outbreak in the United
States
Jenkins, P. and Modlin, J.
Pediatrics 2006.
118(2): 611-618
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239440600022
43.
58960 DMID-LS-127;
WOS-DMID-9/11/2006
Synthesis of 2-Bromomethyl-3-Hydroxy-2-Hydroxymethyl-Propyl Pyrimidine
and Theophylline Nucleosides Under Microwave Irradiation. Evaluation of Their
Activity Against Hepatitis B Virus
El Ashry, E. et al.
Nucleosides Nucleotides & Nucleic Acids 2006. 25(8): 925-939
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239453200009
44.
58961 DMID-LS-127;
WOS-DMID-9/11/2006
A Nutritional Supplement Formula for Influenza a (H5n1) Infection in
Humans
Friel, H. and Lederman, H.
Medical Hypotheses 2006.
67(3): 578-587
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239465700023
45.
58962 DMID-LS-127;
WOS-DMID-9/11/2006
The Hcvns3 Protease Inhibitor Sch 503034 in Combination With Peg-Ifn
Alpha-2b in the Treatment of Hcv-1peg-Ifn Alpha-2b Non-Responders: Antiviral
Activity and Hcv Variant Analysis
Zeuzem, S. et al.
Journal of Hepatology 2006.
44: S35
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000237328100079
46.
58963 DMID-LS-127;
WOS-DMID-9/11/2006
Telbivudine Displays Consistent Antiviral Efficacy Across Patient
Subgroups for the Treatment of Chronic Hepatitis B: Results From the Globe
Study
Thongsawat, S. et al.
Journal of Hepatology 2006.
44: S49
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000237328100111
47.
58964 DMID-LS-127;
WOS-DMID-9/11/2006
Inhibitory Effects of 10-23 Dnazyme on the Expression of Hepatitis B
Virus
Ren, N. et al.
Journal of Hepatology 2006.
44: S150
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000237328100396
48.
58965 DMID-LS-127;
WOS-DMID-9/11/2006
Emergence of Dual-Resistance Hbv Mutations to Adefovir-Dipivoxil and
Lamivudine in a Hepatitis B Patient With Combination Therapy for Adefovir
Resistance
Kwon, S. et al.
Journal of Hepatology 2006.
44: S273-S274
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000237328100741
49.
58966 DMID-LS-127;
WOS-DMID-9/11/2006
Is Combination Antiviral Therapy for Cmv Superior to
Monotherapy?
Drew, W.
Journal of Clinical Virology 2006. 35(4): 485-488
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239545300023
50.
58967 DMID-LS-127;
WOS-DMID-9/11/2006
Early Viral Response to Cpg 10101, a New Investigational Antiviral Tlr9
Agonist, in Combination With Pegylated Interferon and/or Ribavirin, in Prior
Relapse Hcv Responders: Preliminary Report of a Randomized Phase 1
Study
Mchutchison, J. et al.
Gastroenterology 2006.
130(4): A784
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000236961706056
51.
58968 DMID-LS-127;
WOS-DMID-9/11/2006
Exogenous Nitric Oxide Inhibits Crimean Congo Hemorrhagic Fever
Virus
Simon, M. et al.
Virus Research
2006. 120(1-2):
184-190
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000239294800020